Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Evidence: ComparatorOnlyEvidence: Remission of diabetes without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study

Generated Narrative: Evidence 104396

version: 11; Last updated: 2023-12-06 00:47:22+0000

Profiles: ComparatorOnlyEvidence, SingleStudyEvidence

url: https://fevir.net/resources/Evidence/104396

identifier: FEvIR Object Identifier/104396

name: ComparatorOnlyEvidence_Remission_of_diabetes_without_bariatric_surgery_Control_Group_in_JAMA_2018_Norwegian_cohort_study

title: ComparatorOnlyEvidence: Remission of diabetes without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study

status: Active

date: 2022-09-19 21:15:57+0000

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

author: Brian S. Alper:

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationComparatorOnlyEvidence
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationSingleStudyEvidence

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

relatedArtifact

type: Derived From

Documents

-Url
*https://jamanetwork.com/journals/jama/fullarticle/2669729

relatedArtifact

type: Cite As

citation:

ComparatorOnlyEvidence: Remission of diabetes without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study [Evidence]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 104396. Revised 2022-09-19. Available at: https://fevir.net/resources/Evidence/104396. Computable resource at: https://fevir.net/resources/Evidence/104396.

description:

Risk of Remission of diabetes in control group was 14.8%.

variableDefinition

description:

Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included). -- Comparator Group assigned to no bariatric surgery (specialized medical treatment without bariatric surgery (control group))

variableRole: Population

observed: ComparatorGroup: JAMA 2018 Norwegian cohort study Control cohort

variableDefinition

description:

Remission of diabetes

variableRole: Outcome

observed: OutcomeVariable: Remission of diabetes

synthesisType: not applicable

studyDesign: Observational research, Parallel cohort design, Longitudinal data collection

statistic

description:

141 out of 956 observed with percentage of: 14.8%

statisticType: Proportion

quantity: 0.148

numberAffected: 141

SampleSizes

-NumberOfStudiesNumberOfParticipantsKnownDataCount
*1956956